4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-037576
Options or other derivatives
- Chief Legal Officer acquired 170,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Oltmans Curtis Gale · Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +170,000 | 170,000 | D |
Loading xslF345X05/ownership.xml…